5-hydroxydopamine has been researched along with Neuroblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eggert, K; Neff, F; Noelker, C; Schlegel, J | 1 |
Mazzio, E; Soliman, KF | 1 |
2 other study(ies) available for 5-hydroxydopamine and Neuroblastoma
Article | Year |
---|---|
Signaling pathways mediate the neuroprotective effects of GDNF.
Topics: 14-3-3 Proteins; Gene Expression Regulation, Neoplastic; Glial Cell Line-Derived Neurotrophic Factor; Humans; Hydroxydopamines; Neoplasm Proteins; Nerve Growth Factors; Neuroblastoma; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Polymerase Chain Reaction; Signal Transduction; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 2002 |
Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Hydrogen Peroxide; Hydroxydopamines; Neuroblastoma; Neuroprotective Agents; Parkinson Disease; Pyruvic Acid; Tumor Cells, Cultured | 2003 |